Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROCEPT BioRobotics Corp Director's Dealing 2021

Sep 15, 2021

31665_dirs_2021-09-14_8a9380fe-e104-41df-bde7-6e7370e1987d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PROCEPT BioRobotics Corp (PRCT)
CIK: 0001588978
Period of Report: 2021-09-14

Reporting Person: Shiblaq Hisham (SVP, Commercial Operations)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 43859 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $4.56 2029-04-05 Common Stock (145496.0) Direct
Stock Option (Right to Buy) $5.1775 2030-12-16 Common Stock (31578.0) Direct
Stock Option (Right to Buy) $5.1775 2030-12-16 Common Stock (31578.0) Direct
Stock Option (Right to Buy) $7.2675 2031-06-22 Common Stock (86315.0) Direct

Footnotes

F1: The Stock option was granted on April 5, 2019 and vests 10/46th on the ten month anniversary of the vesting commencement date of March 25, 2019 and the remaining vest monthly over a three year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.

F2: The Stock option was granted on December 16, 2020 and vests on each monthly anniversary of the grant date over a four year period, subject continued employment or service to the Issuer through the applicable vesting date.

F3: The Stock option was granted on December 16, 2020 and vests 25% on the first anniversary of the grant date and the remainder vests on each monthly anniversary over a three year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.

F4: The Stock option was granted on June 22, 2021 and vests 25% on the six month anniversary of the grant date and the remainder vests on each monthly anniversary over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.